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Microsphere-adenoviral complexes target and transduce the therapy. The development of useful approaches to thera-
glomerulus in vivo. peutic gene transfer to the glomerulus depends on at
Background. Developing new treatments for glomerulone- least two essential components: the accurate delivery
phritis makes the glomerulus a logical target for gene therapy.
of DNA constructs to the glomerular capillary and, onMicrospheres may lodge in the glomerulus, and replication-
arrival, effective intracellular transfer of the nucleotidedeficient recombinant adenoviruses are potent mediators of
gene transfer. We postulated that adenoviral-microsphere com- sequences of interest. Previous studies have demon-
plexes could result in DNA transfer (transduction) into glomer- strated glomerular gene transfer using continuous kidney
ular cells in vivo. perfusion with adenovirus [3], renal artery injection of
Methods. Two adenoviruses, each one containing a luciferase liposome complexes [4–7], or arterial injection of trans-or b-galactosidase (b-gal) transgene expression cassette, were
fected mesangial cell vectors [8, 9]. Each of these ap-complexed to polystyrene microspheres. To assess in vivo glo-
proaches to glomerular gene transfer may be limited bymerular transduction with this tool, male Sprague-Dawley rats
underwent aortic injections with adenovirus linked to 11 or the necessity of invasive surgery or technically complex
16 mm diameter microspheres. ancillary procedures. One of the goals of the present
Results. After 48 hours, adenoviral-microsphere complexes study was to develop a minimally invasive and effective
resulted in transduction of up to 19% of glomeruli per kidney
method for direct glomerular gene transfer.section. Endothelial and mesangial cells were transduced with
Microspheres are recognized to lodge in the glomeru-this approach, and transprotein expression persisted for 21
lus [10] and are thus potential vehicles for shuttling DNAdays. Transduction efficiency was greater in the 16 mm group.
For all rats, there was a strong correlation between kidney to the glomerular capillary. Replication-deficient recom-
luciferase levels and the number of b-gal-positive glomeruli binant adenoviruses are extremely effective mediators
(r 5 0.87), indicating that transgene expression was primarily of gene transfer [11] and would be expected to functionglomerular in location. This was supported by reverse tran-
efficiently if contact with appropriate target tissue canscriptase in situ polymerase chain reaction, which demon-
be attained. In the present studies, we postulated thatstrated glomerular localization of the b-gal transgene.
Conclusions. The aortic injection of adenoviral-microsphere combining the tissue-targeting strength of microspheres
complexes transduces the glomerulus in vivo and may be a with the powerful transduction properties of adenovirus
useful tool in developing approaches to gene therapy of glomer- would result in DNA transfer into cells of the glomerulus
ular disease.
in vivo. To address this question, we constructed adeno-
viral-microsphere complexes and, via aortic injection,
attempted to transduce glomeruli of normal rats. The
Resident glomerular cells may mediate evolution of results of these studies indicate that an adenoviral-
many forms of acute and chronic glomerulonephritis microsphere shuttle system is well tolerated and results
[1, 2], making the glomerulus a logical target for gene in efficient transduction of glomerular endothelial and
mesangial cells. This method may prove to be a useful new
approach for targeting gene therapy to the glomerulus.Key words: gene therapy, acute glomerulonephritis, chronic glomerular
disease, nucleotide sequences, mesangial cell vectors, glomerular gene
transfer, replication-deficient recombinant adenovirus.
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used in these studies was prepared as we have described Co. (Franklin Lakes, NJ, USA) using RPMI 1640 from
GIBCO BRL (Gaithersburg, MD, USA) supplementedin detail elsewhere [12]. In brief, viral stocks of adenovi-
rus-containing expression cassettes composed of the cy- with 10% FCS, penicillin (100 m/mL), streptomycin
(100 m/mL), and amphotericin-B (0.25 mg/mL; GIBCO).tomegalovirus immediate early promoter fused to the
lacZ reporter gene (rAvb-gal; a generous gift of Dr. Phil Approximately 105 cells were transduced with 105 adeno-
viral-microsphere complexes dissolved in the previouslyJohnson, Children’s Hospital, Columbus, OH, USA), or
the distal 459 base pairs of the human transforming mentioned media supplemented with 2% FCS, and/or
the washes derived from the preparation of the adenovi-growth factor (TGF) gene promoter (a generous gift of
Dr. Seong Kim, National Institutes of Health, Bethesda, ral-microsphere complexes. After two hours, the tissue
culture supernatant was removed and replaced with fullMD, USA) fused to a luciferase reporter gene (rAvTGF)
were used in these studies [13]. media. Twenty-four hours later, soluble transgene activ-
ity (luciferase) from cell extracts was determined. InThe rAvb-gal reporter gene codes for the enzyme
b-galactosidase (b-gal), and the rAvTGF construct gen- some studies, tissue transgene expression was assessed
by staining fixed cells for b-gal activity.erates the firefly luciferase transprotein. The adenoviral
amplification and purification procedure is summarized In vivo transduction using adenoviral-microsphere com-
plexes. Male Sprague-Dawley rats weighing 300 to 350 gas follows: Viral recombinants were amplified by mixing
a sample from stock adenovirus with supplemented (Harlan-Sprague Dawley, Indianapolis, IN, USA) were
anesthetized with intraperitoneal pentobarbital (50 mg/kgEarle’s Minimum Essential Medium (EMEM) from
Quality Biologicals (Gaithersburg, MD, USA). The solu- body weight). The left carotid artery was identified via
a small anterior, cervical-thoracic incision and was can-tion was applied to confluent 293 cells obtained from
ATCC (Rockville, MD, USA). After evidence of exten- nulated using polyethylene tubing (PE-50), which was
advanced approximately 3 to 5 cm into the aorta, fol-sive cytopathic effect (3 to 4 days), the virus was recov-
ered following three freeze-thaw cycles and centrifuga- lowed by injection of 1 mL of PBS containing the adeno-
viral-microsphere complexes. The proximal carotid ar-tion. The viral recombinants were purified with cesium
chloride ultracentrifugation and dialyzed [14]. The puri- tery was ligated as the catheter was removed, and the
incision was closed with wound clips. Animals were sacri-fied virus was resuspended in 10% sterile glycerol and
stored at 2708C. ficed after 48 hours or 7, 14, or 28 days, and samples of
kidney, spleen, liver, and lung were taken for assessmentTo determine the titer (TCID50) of the purified virus,
sample dilutions (1023, 1026, and 1029 through 10212) in of transgene activity.
EMEM 1 2% fetal calf serum (FCS) and l-glutamine
Determination of transgene expressionwere made and used to inoculate a 12-well plate con-
taining confluent 293 cells. After three hours, the media Luciferase activity from cultured cells and transduced
kidneys. Luciferase activity from transduced mesangialwere changed, and each well was examined daily for
evidence of cytopathic effect. Appropriate transgene ex- cells was determined from cell extracts obtained as we
have described [12]. In brief, wells were washed with PBS,pression from transduced cells was assessed in parallel
wells [12]. followed by the addition of a single-step cell lysis buffer
(Promega, Madison, WI, USA), scraped with a rubberAdenoviral-microsphere complexes. Adenoviral-micro-
sphere complexes were prepared by coincubating rAvb- policeman, and exposed to a single freeze-thaw cycle,
and the samples were frozen at 2708C until assayed.gal and rAvTGF (109 particles/mL for each construct)
with 106 11 or 16 mm diameter fluorescent polystyrene Tissue luciferase levels from kidney, spleen, liver, and
lung of transduced rats were determined after snap freez-microspheres from Duke Scientific Corporation (Palo
Alto, CA, USA) in borate buffer, pH 8.5. After two ing the sample in liquid nitrogen, pulverizing at 2708C,
and solubilizing in the presence of cell lysis buffer (2.5hours at 48C, the adenoviral-microsphere complexes
were washed four times in phosphate-buffered saline mL/g tissue). After incubation for 30 minutes at 48C and
centrifugation at 1500 r.p.m. for 10 minutes at 48C, the(PBS; pH 7.20) and maintained at 48C on a rotating
shaker until utilized for transduction. supernatant was recovered and stored at 2708C. Lucifer-
ase levels were determined by mixing 20 mL of cell or
Transduction protocols tissue extract with 100 mL of luciferase assay substrate
from Promega and reading immediately in a Lumat LBIn vitro transduction of human mesangial cells with
adenoviral-microsphere complexes. Mesangial cells were 9501 luminometer (Wallac, Gaithersburg, MD, USA).
Kidney expression of the b-gal transgene in transducedisolated from adult human kidneys, deemed unaccept-
able for transplantation, using sieving techniques and rats. Kidney expression of the b-gal transgene was docu-
mented in vivo using reverse transcription-polymerasecollagenase digestion, as we have previously described
[15, 16]. The isolated mesangial cells were cultured in chain reaction (RT-PCR) and RT in situ PCR.
(a) RT-PCR. The total RNA from a single kidney6- or 12-well plates from Falcon, Becton Dickinson and
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Fig. 1. In vitro transduction of cultured human mesangial cells. (A) Soluble luciferase activity from mesangial cells transduced with microspheres
(MS) lacking adenovirus, microspheres complexed to 2 adenoviruses, 1 each bearing a luciferase or lacZ expression cassette (MS 1 rAv), or consecutive
wash solutions from MS 1 rAv immediately following the adsorption reaction. Luciferase activity from cells transduced with MS 1 rAv (after 4
washes) was more than twofold over background (MS only). Luciferase activity from cells transfected with the third wash solution was no different
from background, suggesting that at this point, all transduction was mediated by adenovirus complexed to microspheres and not from free virus in
solution (*P , 0.05 when compared with wash 1). (B) Histologic appearance of b-gal transgene activity (blue color) in transduced mesangial cells.
Most transduced cells are associated with a microsphere (arrows). The presence of wild-type (“untransduced”) cells (purple color) suggests that the
majority of transduction was associated with virus bound to a microsphere since free virus will avidly transduce wild-type mesangial cells [12] (325).
Fig. 3. Histologic appearance of b-gal trans-
gene protein expression (blue color) from the
glomeruli of transduced rats. Microspheres are
indicated by the black arrows. (A–E ) Repre-
sentative glomeruli exhibiting a spectrum of
transduction patterns. These patterns and the
image analysis characteristics of each glomer-
ulus are indicated in Table 2. (F) Higher power
image of the glomerulus illustrated in (E) indi-
cating cytoplasmic staining for the b-gal trans-
gene protein, with relative sparing of the nu-
clei (white arrows).
from either a wild-type or transduced rat, or transduced of 0.1 mg of oligo(dT)18 in a total volume of 13 mL. After
quick chilling in an ice bath, 6 mL of a mixture containing293 cells (as a positive control), was extracted using the
method of Chomczynski and Sacchi [17]. Single-stranded 70 mmol/L Tris, 160 mmol/L KCl, 8 mmol/L MgCl2,
3 mg/mL bovine serum albumin (BSA), 0.33 mmol/L di-cDNA was synthesized from total RNA using an oli-
go(dT)18 primer and recombinant Moloney murine leu- thiothreitol (DTT), 2 mmol/L each of dNTPs, and 33
m/mL RT were added. After 10 minutes at room tempera-kemia virus RT from GIBCO. One microgram of total
RNA was heated to 708C for 10 minutes in the presence ture, 428C for 50 minutes, 908C for 5 minutes, and place-
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ment on ice, 2 m of RNase H were added, and the mixture utes at 48C. The sections were washed twice in PBS
was incubated at 378C for 20 minutes. PCR amplification and stained in a 100 mmol/L sodium phosphate solution
of target cDNA was as follows: 1 mg of cDNA and 100 containing 1.3 mmol/L MgCl2, 3 mmol/L K3Fe(CN)6,
nmol/L of primers recognizing the 59 forward terminus 3 mmol/L K4Fe(CN)6, and 1 mg/mL 5-bromo-4-chloro-
(59-CCGTCGTTTTACAACGTCGTGA-39) and 39 re- 3-indolyl-b-d-galactoside (X-gal) at room temperature
verse terminus (59-ATGTGAGCGAGTAACAACCG for 14 to 16 hours. The sections were counterstained
TCGGATTCT-39) of b-gal mRNA (GIBCO) were with nuclear fast red. The sections were examined by
mixed and cycled at 948C 3 1 minute, 558C 3 1 minute, visual inspection and analyzed using digital analysis.
728C 3 1 minute for a total of 30 cycles, followed by a Light and electron microscopic analysis of transduced
final extension at 728C for 10 minutes. Equal volumes tissue. Each kidney was examined under light micros-
of each PCR product were evaluated with 1.5% agarose copy with the observer blinded to the tissue type. In
gel containing 0.5% ethidium bromide. The product rep- this analysis, all kidneys were examined for evidence
resenting the b-gal transgene was identified at 355 bp. of ischemia and the anatomic (glomerular, tubular, or
(b) RT in situ PCR. Four micron cryostat kidney sec- peritubular) distribution of b-gal transgene expression.
tions from a wild-type and transduced rat were fixed in In b-gal-positive glomeruli, the cellular expression of the
10% buffered formalin for two days and washed in b-gal transgene was determined by examination of 1 m
RNase-free water and 100% ethanol. After air drying, thick sections stained for four hours using X-gal.
the tissues were protease digested (the optimal digestion Glomerular transduction was defined as the presence
time was determined using nonspecific incorporation of of b-gal activity inside Bowman’s capsule. If b-gal-posi-
10 mmol/L digoxigenin dUTP) [18, 19], incubated over- tive glomeruli were noted, the total glomerular count
night in 10 U RNase free-DNase (Boehringer Mann- and number of transduced glomeruli were determined.
heim, Indianapolis, IN, USA), and subjected to one step To determine the intraglomerular distribution of trans-
RT-PCR using the rTth system and digoxigenin dUTP duction in each b-gal (1) glomerulus, the location (inner,
as we have described [18, 19]. Using the previously men- middle, or outer third of the glomerular tuft circumfer-
tioned primer sequences for b-gal, 20 cycles of PCR were ence) of b-gal transgene staining was recorded.
performed, and the slides washed at high stringency (608C The extent of b-gal transgene expression from kidneys
for 10 min in 15 mmol/L NaCl containing 2% bovine transduced with adenoviral-microsphere complexes was
serum albumin) and the digoxigenin-labeled, target-spe- quantitated using digital image analysis. A 24-bit, 325
cific cDNA detected after a 30 minute incubation at 378C magnified digital image of every b-gal-positive glomeru-
with 1:200 antidigoxigenin-alkaline phosphotase conju- lus from each kidney was prepared using a SPOT digital
gate (Boehringer Mannheim) followed by exposure to
camera (Diagnostic Instruments, Sterling Heights, MI,
nitroblue tetrazolium and bromochloroindolyl phosphate
USA). The surface area of b-gal-positive regions in eachchromogens (Enzo Biochemicals, Farmingdale, NY, USA).
glomerulus was determined with an image analysis soft-The tissues were subsequently counterstained with nu-
ware program from Jandel (SigmaScanPro, San Rafael,clear fast red. Controls for RT in situ PCR included no
CA, USA). In addition, the total surface area of theDNase treatment, the omission of primers, the use of
glomerulus under study was determined, allowing calcu-irrelevant human papillomavirus-specific primers, and
lation of the percentage of the total glomerular surfaceRNase digestion prior to RT in situ PCR. b-gal mRNA
area transduced. Electron microscopic analysis of kid-was indicated by the presence of a blue precipitate.
neys transduced with 16 m diameter beads was performedHistologic preparations for b-gal activity. Histologic
using methods similar to what we have described pre-preparations of transduced mesangial cell cultures or
viously [12]. In brief, tissue was obtained 24 hours follow-organ samples from transduced rats were prepared as
ing transduction. After bisecting the left kidney in thewe have described [12]. In brief, mesangial cells were
longitudinal plane, one half of the tissue mass was dis-grown in chamber slides (Nalge Nunc International, Na-
sected into 1 mm cubes, fixed in glutaraldehyde, imbed-perville, IL, USA), and after washing with PBS, they
ded in Epon, sectioned at 50 to 60 nm, and stained withwere fixed in 5% formalin and 0.05% glutaraldehyde at
uranylacetate and lead acetate. The remaining portionroom temperature for five minutes, washed, stained with
of the kidney was sectioned and stained for b-gal activity.an X-gal solution from GIBCO, and examined by visual
inspection. Kidneys from transduced rats were removed
Statistical analysisat sacrifice and bisected longitudinally, and a portion of
All data are expressed as mean 6 SEM. Groups werethe organ was frozen in cryoprotective medium (OCT;
compared using Student’s t-test, and differences wereSakura Finetek, Torrance, CA, USA) and stored at
considered significant at P value , 0.05. Linear regres-2708C until sectioned. Cryosections (1 to 6 mm) were
sion analysis was used to compare luciferase levels andfixed with 2% formaldehyde and 0.2% glutaraldehyde
in a 100 mmol/L phosphate buffer (pH 7.4) for five min- histologic expression of the b-gal transprotein.
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Fig. 5. Cellular localization of the b-gal trans-
protein (blue color) from transduced rats. (A)
Transduced endothelium (arrow) in direct
proximity to a microsphere (MS). (B ) Trans-
duced mesangial cells (arrow) in a segmental
portion of a glomerular tuft (31250).
Fig. 7. Expression of the b-gal transgene from transduced rat kidney using RT in situ PCR. (A) Low-power view of a representative kidney
section from a rat transduced with microspheres complexed to recombinant adenovirus containing a CMV/lacZ expression cassette. b-gal mRNA
is indicated by the blue pigment, which is localized to the glomerulus (large arrow). There is no signal in tubular cells remote to the transduced
glomerulus (small arrow; 3400). (B ) High-power image of (A) indicating numerous b-gal-positive cells (large arrow). Cells negative for b-gal
activity are indicated by the small arrow (31000). (C ) High-power image of a tubule from (A) showing no b-gal activity (31000). (D ) Representative
glomerulus from a rat injected with microspheres only. There is no evidence of b-gal activity (3400).
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RESULTS
In vitro transduction of cultured human
mesangial cells
Microsphere-adenoviral complexes efficiently trans-
duced human mesangial cells in culture. Figure 1A dem-
onstrates luciferase transgene activity from mesangial
cells transduced with microspheres only or microsphere-
adenoviral complexes. Microspheres containing the ade-
novirus demonstrated over a twofold increase in lucifer-
ase activity when compared with microspheres alone
(P , 0.05). To confirm that transduction resulted from
adenovirus complexed to microspheres and not from free
(unbound) virus, microsphere-adenoviral complexes were
prepared in the borate adsorption buffer, and the super-
natant from consecutive washes was used to transduce
mesangial cells. The luciferase activity generated with
this approach is a reflection of free virus present in the
supernatant after each wash. Luciferase levels progres-
sively declined with each wash, with transgene activity
falling below that of complexed microspheres by the
third wash.
The histologic appearance of cultured mesangial cells
transduced with microsphere-adenoviral complexes is in-
dicated in Figure 1B. The b-gal staining pattern is primar-
ily cytoplasmic, as we have previously shown with free
adenovirus [12]. Virus bound to the microspheres likely
mediated transduction, because luciferase activity from
cells transduced with the adenoviral-microsphere com-
plexes was significantly greater than levels from cells
incubated the final wash solution. This implies that the
majority of the virus was bound to the microspheres and
not free in solution. We have previously shown that as
few as one viral particle per cell can result in transduction
and detectable transprotein levels [12].
In vivo transduction of rat kidney
Table 1 presents clinical data and transgene activity for
individual rats transduced with 16 or 11 mm microspheres
complexed to adenovirus. All rats tolerated the procedure
without evidence of postoperative morbidity or mortality.
At the time of transduction, the weight of rats trans-
duced with 11 mm microspheres was slightly but signifi-
cantly greater than rats transduced with 16 mm microsphere
complexes. Renal function was assessed by measuring
serum creatinine levels. There were no differences in base-
line serum creatinine concentrations between the two
groups; however, 48 hours following transduction, both
groups had modest but significant increases in serum
creatinine.
On histologic evaluation, all kidneys were normal in
appearance and were without evidence of ischemia. There
were no differences between the groups in total number
of glomeruli per kidney section; however, there was trend
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Table 2. Transduction and image analysis patterns of the glomeruli
shown in Figure 3
Figure 3 Microsphere Location of b-gal positive
panel diameter lm b-gal staininga surface areab
A 11 Middle 4.2 (1.5)
B 16 Outer 18 (6.9)
C 16 Inner 39 (8.7)
D 16 Outer 71 (28.1)
E 16 Middle 55 (23)
a Refers to the inner, middle or outer one third of the glomerular tuft circumfer-
ence
b 3103 square pixels. The number in parentheses refers to the percent of the
total glomerular tuft surface area expressing b-gal activity. A description of the
image analysis technique is in the text.
in several glomeruli and are usually contiguous with an
area of positive staining for b-gal. We postulate thatFig. 2. Correlation between soluble kidney luciferase levels and histo-
transduction occurs from adenoviral contact with targetlogic appearance of the b-gal transgene for individual rats transduced
with adenoviral microsphere complexes. A positive correlation (r 5 cells, which is facilitated by the embolized microsphere.
0.87, P , 0.05) between luciferase level and the number of glomeruli Examples of transduction of each third of the glomeru-exhibiting b-gal transgene activity [b-gal (1) glomeruli] was demon-
lar tuft circumference are represented in Figure 3; how-strated.
ever, the majority of the transduction events occurred
in the outer one third of the tuft. The distribution of
b-gal staining for all transduced glomeruli in this study
the 16 mm group (20 6 6 vs. 11 6 7 for 16 mm and indicated that 11 mm microspheres almost exclusively
11 mm groups, respectively). On average, both groups localized to the outer third of the glomerular tuft (89 6
exhibited 47 to 49 microsphere-positive glomeruli per 15%). In contrast, 28 6 17% and 69 6 16% of the 16 mm
kidney section, but the percentage of these glomeruli microspheres were localized to the middle and outer
exhibiting b-gal activity was significantly greater in the thirds of the tuft, respectively.
16 mm group (40 6 5 vs. 19 6 5% for 16 mm vs. 11 mm, The diffuse nature of the b-gal staining in Figure 3
respectively). In the present studies, the expression of suggested that all cell types making contact with a com-
b-gal was limited to the glomeruli and was not demon-
plexed microsphere may be susceptible to transduction.
strable in either the tubules or the interstitium. In con-
Thus, microspheres embolized in the glomerular capil-
trast, the injection of free virus into the renal artery
lary would be expected to make contact with both endo-results primarily in vascular transduction with sparing of
thelial and mesangial cells. To confirm the location ofthe glomerulus [20, 21].
an embolized microsphere relative to target cells, we per-When image analysis was used to compare glomerular
formed electron microscopy on a kidney from a rat sub-surface area of b-gal expression between the two groups,
jected microsphere-adenoviral transduction according tothere was a threefold increase in surface area staining
the previously mentioned transduction protocol. The re-and the percentage of glomerular area expressing the b-
sults of this experiment are shown in Figure 4, which indi-gal transgene (9 6 2 vs. 3 6 1% for 16 mm vs. 11 mm
cates the proximity of both endothelial and mesangialgroups, respectively). There were no differences in stain-
cells to the microsphere. Transduction of both glomeru-ing intensity, but there was a significant increase in b-
lar endothelial and mesangial cells is shown in Figure 5.gal-positive staining area (22 6 4 vs. 8 6 3 3 104 pixels
To demonstrate that the b-gal transgene was success-squared) for 16 versus 11 mm treated rats, respectively.
fully delivered to the kidney, RT-PCR and RT in situ PCRThere were no differences in tissue luciferase levels
for the lacZ gene sequence was performed on kidneysbetween rats injected with 16 or 11 mm microspheres;
isolated from rats injected with microsphere-adenoviralhowever, there was a trend toward higher levels in the
complexes or control animals treated with microspheres16 mm group (618 6 92 vs. 538 6 206). There was a strong
alone. In rats transduced with microsphere-adenoviralcorrelation between luciferase level and both the number
complexes, RT-PCR demonstrated the presence of theof transduced glomeruli and b-gal staining area (Fig. 2).
lacZ nucleotide sequences in the kidney (Fig. 6), andThe histologic appearance and b-gal transgene expres-
RT in situ PCR indicated glomerular localization of thesion for several representative glomeruli are shown in
transgene (Fig. 7). Using both techniques, there was noFigure 3 and the patterns are analyzed in Table 2. As
b-gal expression in control rats. The other controls forcan be seen, the glomeruli are histologically normal and
without evidence of ischemia. Microspheres are evident RT in situ PCR were negative, and RNase digestion
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Fig. 4. Electron micrograph of the glomeru-
lus from a rat transduced with 16 mm micro-
spheres (MS) complexed to adenovirus. (A)
Microsphere lodged in glomerular capillary.
The proximity of mesangial cells (MC) to the
microsphere is evident (31800). (B ) Higher
power view of the same field showing contact
between microsphere and the endothelium. The
epithelial foot processes (closed arrow) and uri-
nary space (asterisk) are indicated (34500).
prior to RT in situ PCR led to a loss of b-gal signal (data
not shown).
Duration and organ distribution of
transgene expression
The duration of transgene expression (luciferase activ-
ity) from transduced kidneys was assessed for up to 28
days. As can be seen in Figure 8, rats transduced with
microsphere-adenoviral complexes exhibited a signifi-
cant increase in kidney luciferase levels for up to 21 days.
Luciferase activity was no different than background
by 28 days. These data are in agreement with previous
reports [20].
To assess the distribution of transduction following
aortic injection, luciferase activity was assessed from kid-
ney, spleen, liver, and lung. As can be seen in Figure 9,
transgene expression was limited to the kidney and
spleen, and was no different from background levels in
both liver and lung.
DISCUSSION
This study is, to our knowledge, the first to demon- Fig. 6. Expression of the b-gal transgene from transduced rat kidney.
strate that a systemic injection of replication-deficient RT-PCR was used to amplify total RNA from a rat transduced with
unmodified (lacking virus) microspheres (rat MS only) or an animalrecombinant adenovirus can successfully target and
injected with microspheres complexed to adenovirus bearing the b-galtransduce the glomerulus. The method uses adenovirus gene (rat MS-rAvb-gal). The b-gal signal from rat MS-rAvb-gal (arrow)
complexed to polystyrene microspheres that, through is of identical size to that amplified from 293 cells transduced with the
b-gal gene [b-gal (1) cont]. There is no signal demonstrable from the ratembolization of the glomerular capillary, facilitate viral
injected with uncoated microspheres. Control lanes include the following:
infection of target cells. The procedure was well tolerated Markers, l HindIII markers; Cont RNA, a control for reverse transcrip-
tion [an 891 bp RNA sequence from the chloramphenicol acetyltransfer-and resulted in successful transduction of up to 19% of
ase gene (provided by the vendor)]; b actin, a control for the presenceglomeruli.
of human mesangial cell RNA; and 100 mers, 100 bp ladder markers.
Other studies have reported successful gene transfer
into the glomerulus using continuous organ perfusion with
adenovirus [3], liposome complexes [4–7], or transfected
mesangial cell vectors [8, 9]. Continuous renal perfusion duced glomeruli was not investigated. Thus, the relative
with adenovirus resulted in successful b-gal transgene pro- contribution of passive deposition of b-gal synthesized by
tein expression in up to 85% of glomeruli [3]. However, transduced liver cells is unknown [22].
Dexoyoligonucleotides encapsulated in liposomal com-in this study, the presence of the b-gal transgene in trans-
Nahman et al: Microsphere-adenoviral complexes and transduction1508
Fig. 8. Duration of kidney transgene expression. Kidney transgene Fig. 9. Organ distribution of transgene expression from transduced
expression (luciferase activity) was measured in rats transduced with rats. For each organ, the mean luciferase level (N 5 4 rats) was calcu-
microsphere-adenoviral complexes at each time point beginning 48 lated and compared using analysis of variance. *P , 0.05 when com-
hours after transduction (d), (N 5 4 rats/time point). The open circles pared to liver and lung. Beads 5 kidney luciferase level from a rat
(s) represent background kidney luciferase levels from rats injected injected with uncoated microspheres.
with uncoated microspheres (N 5 3 rats/time point). When compared
with controls, animals injected with microsphere-adenoviral complexes
had significantly higher luciferase levels for 21 days. There was a gradual
loss of luciferase activity over time with no difference in luciferase
tery cannulation. Finally, the present method may allowlevels 28 days following transduction (*P , 0.05).
for further characterization of in vivo transduction
events occurring at the adenovirus–target cell interface.
For example, fluorescent adenovirus [23] may be com-
plexes resulted in efficient glomerular gene transfer within plexed to microspheres and used to track subcellular
20 minutes [5], two hours [6], and four days [4] of the events associated with transduction in vivo.
injection. Transgene activity was sufficient to suppress In the present studies, adenovirus complexed to 16 mm
glomerular matrix accumulation [5] and transcription microspheres resulted in higher transduction efficiency
factor activity [6]. This approach may be limited by tran- than virus complexed to 11 mm particles. This was re-
sient transgene expression and complexities associated flected by (1) a greater percentage of microsphere-posi-
with vector preparation [7]. tive glomeruli exhibiting transduction (40 6 5 vs. 19 6 5
The direct renal artery injection of transfected mesan- for 16 mm vs. 11 mm, respectively), (2) a larger portion
gial cells was associated with selective glomerular gene of the glomerular surface area staining positive for the
delivery, high transduction efficiency, and sustained trans- b-gal transprotein, and (3) by trends toward a greater
gene expression for up to four weeks [8]. Transformed number of transduced glomeruli and higher tissue lucif-
mesangial cells occupied the glomerular capillary, and erase levels. The lack of difference in tissue luciferase
some cells were shown to exhibit migration into the glo- level between the two microsphere groups is due, at least
merulus. Similar to our studies, a decrement in renal in part, to the small number of animals studied, combined
function was noted in association with glomerular embo- with the highly efficient transduction results from rat
lization, and concerns about long-term histologic change #108. Differences in luciferase levels are significant if this
have been raised [9]. animal is excluded from the analysis (data not shown).
The information presented in the current studies dem- The differences in transduction efficiency between the
onstrates a new approach to glomerular gene transfer two sizes of microspheres may have resulted from (1)
and offers several advantages over previous methods. an increased frequency of glomerular embolization by
First, preparation of the adenoviral-microsphere com- 16 mm microspheres, (2) the smaller size of the animals
plexes is technically simple and highly reproducible. In in the 16 mm group (which was a random event), and/or
addition, the method uses widely available commercial (3) the larger surface area of the 16 mm particles (804 vs.
components. Second, the surgical approach is straightfor- 380 mm2). It is unlikely that the increase in transduction
ward and not technically demanding. Aortic injection of efficiency observed with the 16 mm microspheres resulted
the microsphere-adenoviral complexes takes less than from increased frequency of glomerular embolization,
20 minutes and is associated with no operative morbidity because there were no differences between the two
or mortality. In contrast, all of the above-mentioned groups in the number (and percentage) of glomeruli con-
taining a microsphere. Alternatively, the smaller size ofstudies necessitated laparotomy with selective renal ar-
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the 16 mm-treated rats may have been associated with the glomeruli of our transduced animals was the result of
viral infection of the glomerulus followed by local trans-a decrease in the volume of distribution of injected mi-
crospheres and thus a higher concentration of micro- gene protein production, and not a consequence of hepatic
synthesis, with secondary deposition in the glomeruli [22].spheres delivered to each glomerulus per unit volume
of blood. We postulate that this is unlikely, however, The present studies demonstrated substantial glomer-
ular transgene expression within 48 hours of transduc-on the basis that the number of microsphere-positive
glomeruli was no different between the two groups. We tion, sustained transprotein levels for 21 days, and even-
tual loss of transgene activity by day 28. These data arespeculate that the most plausible explanation for the
difference in transduction rate between the two groups in agreement with previous studies using the injection of
free adenovirus [20]. We postulate that adenoviral-micro-was the increased surface area of the 16 mm particles.
A larger surface area would be expected to bind more sphere complexes composed of adenoviruses exhibiting
prolonged transgene expression [25, 26] could be success-virus and thus confer delivery of a larger number of viral
particles per glomerulus. In addition, the larger particles fully used to transduce the glomerulus for therapeutic
indications necessitating prolonged transgene activity.would theoretically promote transduction by allowing
more virus to make contact with a greater surface area The decrease in glomerular filtration rate observed
following injection of microsphere-adenoviral complexesof target cells. In vitro, the dose of virus and the duration
of contact with target cells are essential variables mediat- likely resulted from (1) glomerular ischemia from mi-
crosphere embolization and (2) local inflammatory re-ing effective viral infection [12, 24].
This work demonstrates a strong correlation between sponses induced by recombinant adenoviruses [27]. The
latter effect will likely be minimized with the use of lesstotal kidney luciferase levels and b-gal-positive glomer-
uli. This finding suggests that nearly all of the transgene immunogenic viruses [25, 28].
Glomerular ischemia from microsphere embolizationexpression was glomerular in origin. However, a substan-
tial portion of transgene expression could be extraglo- limits the applicability of polystyrene microspheres as a
realistic clinical tool and necessitates the developmentmerular if (1) rAvTGF (producing luciferase) transduced
tubulointerstitial or vascular cells with greater affinity of biodegradable microsphere vehicles. In this regard,
biodegradable microspheres composed of albumin, ca-than rAvb-gal and (2) there was a significant amount of
free (not bound to a microsphere) rAvTGF available to sein, or polyesters may be used for in vivo drug delivery
[29–31]. In addition, we have shown that microspherestransduce extraglomerular sites. Although unlikely, we
cannot exclude differences in cellular tropism for each composed of the biodegradable polyester poly(lactide-
co-glycolide) complex with adenovirus and efficientlyviral construct. We postulate, however, that there was
no unbound rAvTGF, due to the lack of hepatic trans- mediate transduction in vitro (unpublished observa-
tions). We hypothesize that the ideal microsphere parti-duction (as seen with the injection of free adenovectors)
[22]. The lack of free virus makes it less likely that selec- cle would (1) be of approximately 16 mm in diameter,
(2) occlude the glomerular capillary long enough to allowtive tubulointerstitial or vascular transduction could
have occurred. The glomerular localization of the b-gal complete adenoviral transduction, and (3) exhibit rapid
dissipation for restoration of normal glomerular bloodand luciferase transproteins contrasts markedly with re-
nal artery injection of free adenovirus in which the ma- flow. The current studies have shown the feasibility of
a microsphere-based system for glomerular targeting andjority of transgene expression in the kidney is localized
to the peritubular capillaries and tubular cells, with no provide important data for the development of a biode-
gradable particle for use in this approach.apparent glomerular transduction [20, 21].
In the present studies, transprotein expression was In these studies, up to 19% of glomeruli were success-
fully transduced. At this level of transduction, approxi-limited to the kidney and spleen, with negligible activity
in liver and lung. We postulate that this occurred because mately 12% of the surface area of these glomeruli exhib-
ited b-gal transprotein expression. It is unclear which(1) the majority of the adenovirus remained bound to
microspheres and (2) the capillary beds of the spleen of these indicators of transduction is of greater clinical
importance in the development of gene therapy for glo-and kidney are readily accessible following aortic injec-
tion. In contrast, the lack of transgene activity in liver merular disease. The physical characteristics of the thera-
peutic construct are likely critical variables. For example,and lung likely resulted from microsphere-adenoviral
trapping in capillary beds proximal to each organ. if the transprotein is secreted by target cells, transduction
of only a few glomerular cells may be adequate to attainIn these studies, we used RT-PCR and RT in situ PCR
to document expression of the b-gal transgene in kidney a therapeutic effect in the entire glomerulus. In contrast,
the effect of a therapeutic antisense sequence or ribo-and glomerulus, respectively, from transduced rats. Con-
trol animals injected with microspheres lacking the virus zyme may be limited to only to those cells transduced,
thus necessitating much higher levels of transduction.did not exhibit b-gal gene expression. These data strongly
support the contention that the b-gal protein detected in In summary, adenoviral-microsphere complexes offer
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